IPVS statement on "Temporary HPV vaccine shortage: Implications globally to achieve equity".
作者信息
Garland Suzanne M, Stanley Margaret A, Giuliano Anna R, Moscicki Anna-Barbara, Kaufmann Andreas, Bhatla Neerja, Woo Yin Ling
机构信息
Reproductive & Neonatal Infectious Diseases, Department of Obstetrics and Gynaecology, University of Melbourne, Director Centre Women's Infectious Diseases Research, Honorary Research Fellow, Infection & Immunity, Murdoch Children's Research Institute, Parkville, VIC, 3052, Australia.
Dept of Pathology, Tennis Court Rd, Cambridge, CB2 1QP, UK.
出版信息
Papillomavirus Res. 2020 Jun;9:100195. doi: 10.1016/j.pvr.2020.100195. Epub 2020 Mar 20.
Abstract
摘要
相似文献
1
IPVS statement on "Temporary HPV vaccine shortage: Implications globally to achieve equity".疫苗免疫全球联盟（Gavi）关于“HPV疫苗临时短缺：对全球实现公平的影响”的声明
Papillomavirus Res. 2020 Jun;9:100195. doi: 10.1016/j.pvr.2020.100195. Epub 2020 Mar 20.
2
IPVS statement moving towards elimination of cervical cancer as a public health problem.IPVS声明：朝着消除宫颈癌这一公共卫生问题迈进。
Papillomavirus Res. 2018 Jun;5:87-88. doi: 10.1016/j.pvr.2018.02.003. Epub 2018 Feb 27.
3
Elimination of cervical cancer depends on HPV vaccination and primary HPV screening.消除宫颈癌依赖于人乳头瘤病毒（HPV）疫苗接种和HPV初筛。
Lancet Infect Dis. 2021 Oct;21(10):1342-1344. doi: 10.1016/S1473-3099(20)30992-0. Epub 2021 May 31.
4
Global elimination of cervical cancer is achievable-with commitment.全球消除宫颈癌是可以实现的——只要有决心。
Lancet Oncol. 2019 Nov;20(11):1467. doi: 10.1016/S1470-2045(19)30647-3.
5
Eliminating cervical cancer: Promising developments in primary prevention.消除宫颈癌：一级预防中的前景进展。
Cancer. 2020 Jan 15;126(2):242-246. doi: 10.1002/cncr.32507. Epub 2019 Sep 26.
6
Increased production and comprehensive guidelines needed for HPV vaccine.需要增加人乳头瘤病毒（HPV）疫苗的产量并制定全面的指导方针。
Lancet. 2020 Feb 1;395(10221):319-321. doi: 10.1016/S0140-6736(19)32976-9.
7
Vaccinating against cervical cancer.接种宫颈癌疫苗。
Bull World Health Organ. 2007 Feb;85(2):89-90. doi: 10.2471/blt.07-020207.
8
[The first HPV vaccine is now available].首款人乳头瘤病毒疫苗现已上市。
Ugeskr Laeger. 2006 Oct 30;168(44):3827-8.
9
Global access to HPV vaccination: what are we waiting for?全球人乳头瘤病毒疫苗接种情况：我们还在等什么？
Lancet. 2009 Dec 12;374(9706):1948-9. doi: 10.1016/S0140-6736(09)61789-X.
10
Global HPV vaccination.全球人乳头瘤病毒疫苗接种
BMJ. 2011 Feb 16;342:d1042. doi: 10.1136/bmj.d1042.
引用本文的文献
1
Barriers and strategies to enhance HPV vaccine uptake in adolescents living with HIV and their guardians in Lilongwe, Malawi.在马拉维利隆圭，提高感染艾滋病毒青少年及其监护人对人乳头瘤病毒（HPV）疫苗接种率的障碍与策略。
Sci Rep. 2025 Sep 1;15(1):32230. doi: 10.1038/s41598-025-03145-x.
2
Acceptance of human papillomavirus vaccine among boys in Asia: A narrative review.亚洲男孩对人乳头瘤病毒疫苗的接受程度：一项叙述性综述。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2429894. doi: 10.1080/21645515.2024.2429894. Epub 2024 Nov 29.
3
Acceptance of Human Papillomavirus (HPV) vaccine among the parents of eligible daughters (9-15 years) in Bangladesh: A nationwide study using Health Belief Model.孟加拉国符合条件的女儿（9-15 岁）的父母对人乳头瘤病毒（HPV）疫苗的接受程度：使用健康信念模型进行的全国性研究。
PLoS One. 2024 Nov 8;19(11):e0310779. doi: 10.1371/journal.pone.0310779. eCollection 2024.
4
Accelerating HPV vaccination in Africa for health equity.加速非洲 HPV 疫苗接种以实现卫生公平。
Glob Health Res Policy. 2024 Sep 19;9(1):37. doi: 10.1186/s41256-024-00380-z.
5
Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials.单剂量人乳头瘤病毒疫苗与多剂量接种方案或未接种疫苗相比的有效性和免疫原性：来自临床试验证据的最新系统评价
Vaccine X. 2024 Apr 16;19:100486. doi: 10.1016/j.jvacx.2024.100486. eCollection 2024 Aug.
6
Inequities in human papillomavirus vaccination among children aged 9-14 years old under constrained vaccine supply in China.中国疫苗供应受限背景下，9-14 岁儿童人乳头瘤病毒疫苗接种的不公平现象。
Int J Equity Health. 2024 May 31;23(1):112. doi: 10.1186/s12939-024-02199-z.
7
Vaccination and screening strategies to accelerate cervical cancer elimination in Norway: a model-based analysis.在挪威加速消除宫颈癌的疫苗接种和筛查策略：基于模型的分析。
Br J Cancer. 2024 Jun;130(12):1951-1959. doi: 10.1038/s41416-024-02682-y. Epub 2024 Apr 20.
8
Human papillomavirus (HPV) vaccination program in Sri Lanka: Ongoing costs and operational context of a routinized program.斯里兰卡的人乳头瘤病毒（HPV）疫苗接种计划：常规计划的持续成本与运营情况
Vaccine X. 2024 Feb 8;17:100456. doi: 10.1016/j.jvacx.2024.100456. eCollection 2024 Mar.
9
The quest for more effective vaccine markets - Opportunities, challenges, and what has changed with the SARS-CoV-2 pandemic.追求更有效的疫苗市场 - 机遇、挑战以及 SARS-CoV-2 大流行带来的变化。
Vaccine. 2024 Apr 8;42 Suppl 1(Suppl 1):S64-S72. doi: 10.1016/j.vaccine.2022.07.032. Epub 2022 Oct 21.
10
Recent Developments in Human Papillomavirus (HPV) Vaccinology.人乳头瘤病毒（HPV）疫苗学的最新进展。
Viruses. 2023 Jun 26;15(7):1440. doi: 10.3390/v15071440.
本文引用的文献
1
Association of State Opioid Duration Limits With Postoperative Opioid Prescribing.州级阿片类药物持续时间限制与术后阿片类药物处方的关联。
JAMA Netw Open. 2019 Dec 2;2(12):e1918361. doi: 10.1001/jamanetworkopen.2019.18361.
2
Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts.印度在宫颈癌预防工作中 HPV 疫苗接种的现状。
Lancet Oncol. 2019 Nov;20(11):e637-e644. doi: 10.1016/S1470-2045(19)30531-5.
3
Human papillomavirus vaccine disease impact beyond expectations.人乳头瘤病毒疫苗疾病影响超出预期。
Curr Opin Virol. 2019 Dec;39:16-22. doi: 10.1016/j.coviro.2019.06.006. Epub 2019 Aug 2.
4
Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis.一剂人乳头瘤病毒疫苗与三剂一样有效吗？一项全国队列分析。
Papillomavirus Res. 2019 Dec;8:100177. doi: 10.1016/j.pvr.2019.100177. Epub 2019 Jul 15.
5
Status of HPV vaccine introduction and barriers to country uptake.HPV 疫苗接种状况及国家引入的障碍。
Vaccine. 2018 Aug 6;36(32 Pt A):4761-4767. doi: 10.1016/j.vaccine.2018.02.003. Epub 2018 Mar 23.
6
IPVS statement moving towards elimination of cervical cancer as a public health problem.IPVS声明：朝着消除宫颈癌这一公共卫生问题迈进。
Papillomavirus Res. 2018 Jun;5:87-88. doi: 10.1016/j.pvr.2018.02.003. Epub 2018 Feb 27.
7
Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies.二价 HPV 疫苗单次接种保护效力的证据——哥斯达黎加 HPV 疫苗试验及未来研究综述。
Vaccine. 2018 Aug 6;36(32 Pt A):4774-4782. doi: 10.1016/j.vaccine.2017.12.078. Epub 2018 Feb 1.
8
A novel trivalent HPV 16/18/58 vaccine with anti-HPV 16 and 18 neutralizing antibody responses comparable to those induced by the Gardasil quadrivalent vaccine in rhesus macaque model.一种新型三价人乳头瘤病毒16/18/58疫苗，在恒河猴模型中产生的抗人乳头瘤病毒16和18中和抗体反应与加德西四价疫苗诱导的反应相当。
Papillomavirus Res. 2017 Jun;3:85-90. doi: 10.1016/j.pvr.2017.02.005. Epub 2017 Mar 1.
9
Human papillomavirus vaccines: WHO position paper, May 2017.人乳头瘤病毒疫苗：世界卫生组织立场文件，2017年5月
Wkly Epidemiol Rec. 2017 May 12;92(19):241-68.
10
Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis.全球各地区和收入水平的人乳头瘤病毒疫苗接种覆盖率估计：汇总分析。
Lancet Glob Health. 2016 Jul;4(7):e453-63. doi: 10.1016/S2214-109X(16)30099-7.
Zotero 插件